100.31 +0.04 (0.04%)
After hours: 6:10PM EDT
|Bid||100.25 x 300|
|Ask||100.57 x 400|
|Day's range||100.12 - 102.18|
|52-week range||96.66 - 123.55|
|PE ratio (TTM)||25.84|
|Earnings date||19 Apr 2018|
|Forward dividend & yield||4.28 (4.21%)|
|1y target est||120.07|
The Food and Drug Administration is taking the first step toward implementing a rule about the role that flavors, including menthol, play in attracting users to certain tobacco products.
The Food and Drug Administration will consider restricting the use of menthol flavoring in cigarettes, the second move in a week by the agency to make smoking less enjoyable as part of an ambitious anti-tobacco ...
When analysts raise their target prices, stock prices tend to rise, and vice versa. Of the 17 analysts that follow Philip Morris, 58.8% are favoring a “buy,” and 41.2% are favoring a “hold.” None of the analysts are recommending a “sell.” In the next 12 months, analysts are expecting the stock to reach $120.07, which represents a return potential of 14.4%. Since the announcement of its 4Q17 earnings, Jefferies has cut its target price from $124 to $121, while Cowen and Company has reduced its target price from $133 to $120.
On March 1, 2018, Altria Group (MO) announced dividends of $0.70 per share to be paid on April 10, 2018, to shareholders of record as of March 15, 2018. Altria also rewards its shareholders with share repurchases, which reduce the number of shares outstanding, thus boosting the company’s EPS (earnings per share). The company’s management also authorized a new $1 billion share repurchase program in January 2018, which is expected to be completed in 2018.
In 4Q17, Altria Group (MO) posted EPS (earnings per share) of $2.60. The growth was driven by the expansion of net margins and by share repurchases in the last four quarters. Altria’s management has set the company’s 2018 EPS guidance at $3.90–$4.03, which represents a growth of 15%–18.9% from $3.39 in 2017.
Analysts are expecting Philip Morris International (PM) to post revenue of $31.9 billion in 2018, which represents a rise of 11% from $28.8 billion in 2017. The company’s management expects currency-neutral revenue growth at approximately 8%. Revenue growth is expected to be driven by an increase in product prices and growth in RRP (reduced risk products) sales.
In 4Q17, Philip Morris International (PM) posted net revenue of $8.3 billion, which represents growth of 19% from $7 billion in 4Q16. Growth was driven by an increase in total shipment volume of 3.8% and favorable pricing. Philip Morris had a strong performance in the European Union, Asia, Latin America, and Canada.
WASHINGTON (AP) — Federal health officials took the first step Thursday to slash levels of addictive nicotine in cigarettes, an unprecedented move designed to help smokers quit and prevent future generations from getting hooked.
U.S. health officials took the first concrete steps toward cutting the nicotine content in cigarettes to nonaddictive levels, opening a public inquiry ahead of proposed regulations to lower nicotine levels....
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Children in 21 countries are being exposed to promotions by tobacco companies, with cigarettes and advertising appearing close to schools
NEW YORK--(BUSINESSWIRE)-- Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE: PM) today declared a regular quarterly dividend of $1.07 per common share, payable on April ...
As the FDA meets to plan next year's flu vaccine, companies like Medicago are testing innovative technologies designed to minimize the risk of another devastating outbreak.
The tobacco giant's first-mover status was aided by cultural differences that may be hard for competitors to beat.